Page last updated: 2024-10-18

glyceraldehyde and HIV

glyceraldehyde has been researched along with HIV in 1 studies

Glyceraldehyde: An aldotriose containing the propionaldehyde structure with hydroxy groups at the 2- and 3-positions. It is involved in the formation of ADVANCED GLYCOSYLATION END PRODUCTS.
glyceraldehyde : An aldotriose comprising propanal having hydroxy groups at the 2- and 3-positions. It plays role in the formation of advanced glycation end-products (AGEs), a deleterious accompaniment to ageing.
aldose : Aldehydic parent sugars (polyhydroxy aldehydes H[CH(OH)]nC(=O)H, n >= 2) and their intramolecular hemiacetals.

HIV: Human immunodeficiency virus. A non-taxonomic and historical term referring to any of two species, specifically HIV-1 and/or HIV-2. Prior to 1986, this was called human T-lymphotropic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV). From 1986-1990, it was an official species called HIV. Since 1991, HIV was no longer considered an official species name; the two species were designated HIV-1 and HIV-2.

Research Excerpts

ExcerptRelevanceReference
"EFdA (4'-ethynyl-2-fluoro-2'-deoxyadenosine), a nucleoside reverse transcriptase inhibitor with extremely potent anti-HIV activity, was concisely synthesized from (R)-glyceraldehyde acetonide in an 18% overall yield by a 12-step sequence involving highly diastereoselective ethynylation of an α-alkoxy ketone intermediate."3.78Concise synthesis of the anti-HIV nucleoside EFdA. ( Kageyama, M; Kuwahara, S; Miyagi, T; Nagasawa, T; Ohrui, H; Yoshida, M, 2012)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kageyama, M1
Miyagi, T1
Yoshida, M1
Nagasawa, T1
Ohrui, H1
Kuwahara, S1

Other Studies

1 other study available for glyceraldehyde and HIV

ArticleYear
Concise synthesis of the anti-HIV nucleoside EFdA.
    Bioscience, biotechnology, and biochemistry, 2012, Volume: 76, Issue:6

    Topics: Anti-HIV Agents; Deoxyadenosines; Glyceraldehyde; HIV; HIV Reverse Transcriptase; Humans; Magnetic R

2012